"Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage
Key Players discussed in Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Report -
A2K Technologies,Abbott Diagnostics,Abcodia Ltd.,Acobiom,Advanced Marker Discovery, S.L.,Advpharma Inc.,Ambergen, Inc.,Ambrilia Biopharma Inc.,Arizona State University,ArtemixRx,Asuragen, Inc.,Bio Mark Ltd,Biocartis SA,Biodesix Inc.,BioMarCare Technologies Ltd.,BioMark Diagnostics Inc.,BioMarker Strategies, LLC,bioMerieux S.A.,Biomoda, Inc.,Biosceptre (Aust) Pty Ltd,BioSystems International,Biotechnostics GmbH,BioTime, Inc.,Biotron Limited,Castle Biosciences Incorporated,Cellmid Limited,Ceres Nanosciences, Inc.,Cernostics Inc.,China Sky One Medical, Inc.,Chronix Biomedical, Inc.,Cleveland Diagnostics Inc.,ColoPrev,Columbia University,Courtagen Life Sciences, Inc.,CS-Keys, Inc.,Di.V.A.L Toscana srl ,Diadexus Inc,DiagnoCure Inc.,Diaxonhit S.A.,EDP Biotech Corporation,Epigenomics AG,Eventus Diagnostics, Inc.,Exact Sciences Corporation,Exiqon A/S,Exosomics Siena SpA,Fina Biotech,GenomicTree, Inc.,Ghent University,GlycoZym,Health Discovery Corporation,Human Metabolome Technologies, Inc.,Ikonisys, Inc.,InterGenetics Incorporated,IV Diagnostics, Inc.,John Hopkins University,Lab21 Limited,Laboratorios Alpha San Ignacio Pharma S.L.,Lightsphere Diagnostics,LX Diagnostics,MabCure Inc.,Matrix-Bio, Inc.,Max-Delbruck-Centrum fur Molekulare Medizin (MDC),MDNA Life Sciences, Inc.,MDxHealth SA,Merrimack Pharmaceuticals, Inc.,Metabiomics Corporation,Metabolomic Technologies Inc.,Metabolon, Inc.,MetaStat, Inc.,Milagen, Inc.,Miraculins Inc.,Mode Dx Ltd.,Moscow Institute of Physics and Technology,Myriad Genetics, Inc.,Nanosphere, Inc.,NetScientific Plc,Norda ASA,Novel Bio-spectrum Technologies, Inc.,Nuclea Biotechnologies Inc.,Nuvera Biosciences, Inc.,Oncimmune (USA) LLC,OncoVista Innovative Therapies, Inc.,On-Q-ity, Inc.,Origin Sciences Limited,Orion Genomics LLC,OTraces Inc.,Oxford Cancer Biomarkers,Oxford Gene Technology Limited,Panacea Pharmaceuticals, Inc.,PleX Diagnostics,Precision Biologics, Inc.,Prediction Sciences,Protagen AG,Rabin Medical Center,Rosetta Genomics Ltd,Scienion AG,Seegene, Inc.,Shuwen Biotech Co. Ltd.,Siamab Therapeutics, Inc.,Skuldtech France,Sysmex Corporation,Tel Aviv University,The Chinese University of Hong Kong,The Walter and Eliza Hall Institute of Medical Research,TheraDiag SA,Theranostics Health, Inc.,Todos Medical,Universal Diagnostics, S. L.,Universite De Lyon,University of Alabama at Birmingham,University of Illinois at Chicago,University of Texas at Austin,US Biomarkers, Inc.,Vanderbilt University,Vermillion, Inc.,Viomics Inc.,Vitatex Inc.,VolitionRX Ltd.,XEPTAGEN SpA
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development.
It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products.
Access Complete report of 288 pages @ www.rnrmarketresearch.com/contact…ame=662393
Scope
- Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Request Sample for this Market Research Report @ www.rnrmarketresearch.com/contact…ame=662393
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
For more information:
News From
RnR Market Research Category: Industry Reports & Market Analysis Profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
